RedHill Biopharma Ltd.: Q3 results did not meet expectations mainly with GI drug sales; financially, capital raising of $20.6M (NIS 1.94 per share) positions Redhill with sufficient funds until 2018.

• jaimeuss_admin
• 17 בSeptember 2018
• Research
• 0 Comments

Continue Reading

Energix Renewable Energies Ltd.: Completion of stage II connection to the company’s flagship Polish project and successful capital raising are positive indicators. We have raised the price target to NIS 3.82.

• jaimeuss_admin
• 6 בSeptember 2018
• Research
• 0 Comments

Continue Reading